Fidelity Investments’s Bright Minds Biosciences DRUG Stock Holding History
Bought
Maintained
Sold
Other funds holding DRUG
Fidelity Investments's DRUG Position: Q3 2026 in Review
Fidelity Investments increased its Bright Minds Biosciences (DRUG) stake by 619% in Q3 2026, buying an estimated $3.43M and bringing the position to 56,476 shares worth $2.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2666.
Fidelity Investments first reported a position in DRUG in Q2 2025 and has held it in 6 quarters since. 109 funds tracked by Wall St. Rank hold DRUG as of Q3 2026.
- Fidelity Investments held 56,476 shares of Bright Minds Biosciences worth $2.81M as of Q3 2026.
- Fidelity Investments bought 48,625 Bright Minds Biosciences shares in Q3 2026, an estimated $3.43M.
- Bright Minds Biosciences made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #2666 holding.
- Fidelity Investments first reported a position in Bright Minds Biosciences in Q2 2025 and has held it in 6 quarters since.
- 109 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.